HDAC3 and cancer: For example, HD3 with improved binding affinity to histidine, as well as with modified nucleic acids in the target gene-binding sequence for improved binding affinity and nuclease resistance, may serve as a tissue-specific biotool for cancer cells that take up a lot of histidine.